JSNC 2025 in Nagoya

We are delighted to announce that the 35th Annual Meeting of the Japanese Society of Nuclear Cardiology (JSNC 2024) will be held on June 27–28, 2025, at the Nagoya Convention Center in Nagoya, Japan.

Since the advent of noninvasive nuclear cardiology imaging in the 1970s, marked by the development of radionuclide angiography and myocardial perfusion imaging (MPI), nuclear cardiology has become well-established, not only for the accurate diagnosis of myocardial ischemia but also for providing prognostic information in patients with various heart disorders using a range of radiopharmaceuticals.

Recently, nuclear cardiology has also played a crucial role in diagnosing and guiding treatment for conditions such as microvascular disease, cardiac amyloidosis, cardiac sarcoidosis, and triglyceride deposit cardiomyovasculopathy (TGCV). We aim to engage in extensive discussions on how far we can advance our understanding of such disorders by Nuclear Cardiology using new technologies like artificial intelligence et al.

As such, we have chosen “Deep Dive into the Pathophysiology by Nuclear Cardiology” as the main theme of this conference.

We eagerly await numerous submissions from our society members. We are also accepting applications for the Japanese Society of Nuclear Cardiology Award, the Japanese Society of Nuclear Cardiology Technologist Award, and the Young Investigators Award. We look forward to receiving many applications.

We are diligently preparing an engaging and informative program for medical and medical staff. We really looking forward to the active participation of all attendees.

Sincerely,

Hitoshi Matsuo, MD, PhD.

Masayasu Nakagawa, MD, PhD.

Meeting chairpersons of the 35th Annual Meeting of the Japanese Society of Nuclear Cardiology.